ClassID:

109146

C12N2310/141 - page 7 - CPC Classification

Classification description:

Structure or type of the nucleic acid; Type of nucleic acid interfering N.A. MicroRNAs, miRNAs

Recent Application in this class:
#1801
20160151406
2016-06-02

COMBINATION CANCER THERAPY WITH C-MET INHIBITORS AND SYNTHETIC OLIGONUCLEOTIDES

#1802
20160145628
2016-05-26

NANOCARRIER SYSTEM FOR MICRORNAS AND USES THEREOF

#1803
20160145615
2016-05-26

AGONISTS OF DDAH1 FOR TREATING ENDOTHELIAL DYSFUNCTION

#1804
20160145611
2016-05-26

Age-related macular degeneration treatment

#1805
20160145609
2016-05-26

Micro-RNA family that modulates fibrosis and uses thereof

#1806
20160145608
2016-05-26

Micro-RNA family that modulates fibrosis and uses thereof

#1807
20160145607
2016-05-26

Micro-RNA family that modulates fibrosis and uses thereof

#1808
20160143995
2016-05-26

Method of treating intracellular infection

#1809
20160138041
2016-05-19

Identification of a resistance gene from pepper () and method for generating plants with resistance

#1810
20160138020
2016-05-19

MicroRNA and methods for inhibiting same

#1811
20160138018
2016-05-19

Anti-miR-27b and anti-miR-148a oligonucleotides as therapeutic tools for treating dyslipidemias and cardiovascular diseases

#1812
20160138017
2016-05-19

Microrna and uses in brown fat differentiation

#1813
20160136181
2016-05-19

MICRORNA DOSING REGIMENS

#1814
20160135438
2016-05-19

Isolation of novel AAV's and uses thereof

#1815
20160130577
2016-05-12

NUCLEOTIDE SEQUENCE MOTIFS DIRECTING NUCLEIC ACID LOCATION TO EXTRACELLULAR VESICLES

#1816
20160130555
2016-05-12

Methods for maturing cardiomyocytes and uses thereof

#1817
20160129017
2016-05-12

SHIP INHIBITION TO COMBAT OBESITY

#1818
20160122763
2016-05-05

Replication factor C-40 (RFC40/RFC2) as a prognostic marker and target in estrogen positive and negative and triple negative breast cancer

#1819
20160122762
2016-05-05

METHODS OF TREATING ATHEROSCLEROSIS

#1820
20160115475
2016-04-28

Treatment of insulin resistance through inhibitors of transcription factor TSC22D4

#1821
20160113883
2016-04-28

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

#1822
20160108405
2016-04-21

LUNG CANCER DIAGNOSTICS AND THERAPEUTICS WITH MIR-660

#1823
20160108402
2016-04-21

Methods for diagnosing and treating learning or mental disorders

#1824
20160108397
2016-04-21

Targeting microRNAs for the treatment of fibrosis

#1825
20160108108
2016-04-21

Inflammatory disease diagnosis and methods of treatment using lipopolysaccharides-responsive beige-like anchor

#1826
20160102303
2016-04-14

Method of isolating nucleic acid

#1827
20160090597
2016-03-31

Methods to prevent and treat autosomal dominant non-syndromic hearing loss

#1828
20160089390
2016-03-31

Use of MicroRNA or inhibitors thereof in regulation of lipid metabolism

#1829
20160083790
2016-03-24

Regulator targetting fatty acid synthase and method of using the same for improving meat quality

#1830
20160083727
2016-03-24

MiRNA for regulating FABP6 gene and method of using the same

#1831
20160082049
2016-03-24

METHODS, SYSTEMS, AND COMPOSITIONS RELATING TO TREATMENT OF NEUROLOGICAL CONDITIONS, DISEASES, AND INJURIES AND COMPLICATIONS FROM DIABETES

#1832
20160076039
2016-03-17

Pharmaceutical composition for treating liver diseases

#1833
20160076026
2016-03-17

DIAGNOSTIC AND THERAPEUTIC METHODS RELATING TO MICRORNA-144

#1834
20160068842
2016-03-10

miR-29 mimics and uses thereof

#1835
20160068841
2016-03-10

Cancer treatment methods using remote conditioning

#1836
20160060697
2016-03-03

Compositions and Methods for Evaluating Heart Failure

#1837
20160060629
2016-03-03

Synthetic mimics of miR-124

#1838
20160060624
2016-03-03

Huntington's disease therapeutic compounds

#1839
20160060623
2016-03-03

METHOD OF REGULATING NFATC2 ACTIVITY IN LYMPHOCYTES

#1840
20160058923
2016-03-03

Compositions and methods for reducing neointima formation

#1841
20160053270
2016-02-25

RNAi-mediated inhibition of histamine receptor H1-related conditions

#1842
20160053264
2016-02-25

SYNTHETIC MIMICS OF MIR-34

#1843
20160053258
2016-02-25

Composition for controlling stem cells pluripotency, containing LIN28A methylation inhibitor, and method for screening for LIN28A methylation inhibitor

#1844
20160053257
2016-02-25

Method for assaying microRNA, cancer therapeutic agent, and medicinal composition containing same for cancer therapy

#1845
20160051687
2016-02-25

Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

#1846
20160047004
2016-02-18

Viral and viral associated miRNAs and uses thereof

#1847
20160046941
2016-02-18

Targeting microRNAs for the treatment of liver cancer

#1848
20160046940
2016-02-18

Targeting microRNAs for metabolic disorders

#1849
20160046935
2016-02-18

HSA-MIR-146B-5P-related nucleic acids and uses thereof

#1850
20160046934
2016-02-18

Signal activated RNA interference

#1851
20160045512
2016-02-18

Inhibitors of Hemopoietic Cell Kinase (P59-HCK) and Their Use in the Treatment of Influenza Infection

#1852
20160040170
2016-02-11

Long interfering nucleic acid duplexes targeting multiple RNA targets

#1853
20160038598
2016-02-11

Modified Poly(Beta-Amino Ester)s for Drug Delivery

#1854
20160032287
2016-02-04

Method of deriving mature hepatocytes from human embryonic stem cells

#1855
20160032242
2016-02-04

Role for the perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway

#1856
20160024503
2016-01-28

miRNA BIOGENESIS IN EXOSOMES FOR DIAGNOSIS AND THERAPY

#1857
20160024501
2016-01-28

Methods for including cardiomyocyte proliferation

#1858
20160022836
2016-01-28

MiR-204 and miR-211 and uses thereof

#1859
20160022742
2016-01-28

Medicament for liver regeneration and for treatment of liver failure

#1860
20160017338
2016-01-21

MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT

#1861
20160017326
2016-01-21

MICRORNAS AS FUNCTIONAL MEDIATORS AND BIOMARKERS OF BONE METASTASIS

#1862
20160017321
2016-01-21

Method for expressing, secreting and transferring functional microRNAs/siRNAs and application thereof

#1863
20160017292
2016-01-21

Selective targeting of cancer stem cells

#1864
20160017290
2016-01-21

METHODS OF INCREASING INSULIN CONTENT IN CELLS

#1865
20160010087
2016-01-14

Method for treating and/or preventing myopia

#1866
20160008397
2016-01-14

Immunomodulation by controlling expression levels of microRNAs in dendritic cells

#1867
20160003808
2016-01-07

MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF DISEASES ASSOCIATED WITH EPITHELIAL MESENCHYMAL TRANSITION

#1868
20160002639
2016-01-07

NUCLEIC ACIDS INVOLVED IN VIRAL INFECTION

#1869
20160000940
2016-01-07

miRNA profiling compositions and methods of use

#1870
20160000821
2016-01-07

Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone-associated medical conditions

#1871
20150376613
2015-12-31

Segmented micro RNA mimetics

#1872
20150374812
2015-12-31

CELL LINES FOR VIRUS PRODUCTION AND METHODS OF USE

#1873
20150368651
2015-12-24

Furin-knockdown bi-functional RNA

#1874
20150368649
2015-12-24

Genetic control method and compositions against insect pests in cotton plants by the silencing of genes of the laccase family

#1875
20150361431
2015-12-17

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

#1876
20150353991
2015-12-10

MiRNA targets

#1877
20150352215
2015-12-10

Plants as functional microRNA and/or functional siRNA carriers, preparation methods and uses thereof

#1878
20150352046
2015-12-10

Methods and compositions involving miRNA and miRNA inhibitor molecules

#1879
20150344892
2015-12-03

Oligonucleotides for modulation of target RNA activity

#1880
20150344886
2015-12-03

RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis

#1881
20150344883
2015-12-03

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

#1882
20150344881
2015-12-03

Methods and compositions involving miRNA and miRNA inhibitor molecules

#1883
20150344880
2015-12-03

Compositions and methods related to miRNA modulation of neovascularization or angiogenesis

#1884
20150337332
2015-11-26

Methods and compositions to modulate RNA processing

#1885
20150337302
2015-11-26

Biological control of coleopteran pests

#1886
20150329907
2015-11-19

Biomarkers and treatments for heart failure

#1887
20150329861
2015-11-19

MiRNA modulators of thermogenesis

#1888
20150328249
2015-11-19

MODULATION OF MYOFIBER REPAIR BY ANTI-MYOSTATIN STRATEGIES AND/OR PPAR GAMMA LIGANDS, ALONE OR IN COMBINATION WITH STEM CELLS, FOR THE THERAPY OF CRITICAL LIMB ISCHEMIA AND OTHER ISCHEMIC PROCESSES AFFECTING THE SKELETAL MUSCLE

#1889
20150322529
2015-11-12

Compositions and methods for diagnosis, prognosis and treatment of hematological malignancies

#1890
20150322430
2015-11-12

Treatment of B-cell lymphoma with microRNA

#1891
20150320835
2015-11-12

Manipulation of hairy and enhancer of split 3 (Hes3) and its regulators/mediators as an anti-cancer strategy

#1892
20150315592
2015-11-05

Transferrin/transferrin receptor-mediated siRNA delivery

#1893
20150315585
2015-11-05

Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers

#1894
20150315578
2015-11-05

Identification of novel genes coding for small temporal RNAs

#1895
20150315559
2015-11-05

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#1896
20150315545
2015-11-05

Method of rapidly inducing large-scale and high-purity mesenchymal stem cells to transdetermine into hematopoietic stem cells

#1897
20150313932
2015-11-05

Composition and method for treating a hematological malignancy

#1898
20150307879
2015-10-29

ANOIKIS RESISTANT PLACENTAL STEM CELLS AND USES THEREOF

#1899
20150306127
2015-10-29

miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers

#1900
20150299789
2015-10-22

Competitive modulation of microRNAs

#1901
20150299717
2015-10-22

Transgenic plants with modified sugar content and methods of generating same

#1902
20150299706
2015-10-22

Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer

#1903
20150299705
2015-10-22

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

#1904
20150299699
2015-10-22

MICROMIRs

#1905
20150297626
2015-10-22

Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway

#1906
20150297611
2015-10-22

Inhibition of histone methyltransferase for cardiac reprogramming

#1907
20150292031
2015-10-15

Treatment of angiogenesis disorders

#1908
20150291980
2015-10-15

Cell capable of producing adeno-associated virus vector

#1909
20150291962
2015-10-15

Extraction, preparation, and application of plant micro-ribonucleic acid

#1910
20150291959
2015-10-15

Diagnosis and treatment of endometriosis

#1911
20150284720
2015-10-08

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

#1912
20150284719
2015-10-08

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

#1913
20150284718
2015-10-08

miRNA169 compositions and methods for the regulation of carbohydrate metabolism and flowering in plants

#1914
20150283205
2015-10-08

THY1 (CD90) as a novel therapy to control adipose tissue accumulation

#1915
20150275230
2015-10-01

Method for establishing modified host cell

#1916
20150275213
2015-10-01

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

#1917
20150275210
2015-10-01

Inhibiting migration of cancer cells

#1918
20150275209
2015-10-01

COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNOTHERAPY

#1919
20150275189
2015-10-01

Polypeptides having peroxygenase activity

#1920
20150273054
2015-10-01

Modulation of CCR10 signals for treatment of skin and intestinal inflammatory diseases and infection

#1921
20150272886
2015-10-01

Lipidosome preparation, preparation method and application thereof

#1922
20150267259
2015-09-24

METHOD OF PROGNOSIS AND STRATIFICATION OF OVARIAN CANCER

#1923
20150267193
2015-09-24

MicroRNAs and Methods of Using Same

#1924
20150267184
2015-09-24

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#1925
20150259700
2015-09-17

Transgenic Plants With RNA Interference-Mediated Resistance Against Root-Knot Nematodes

#1926
20150259689
2015-09-17

Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)

#1927
20150259651
2015-09-17

Polypeptides having peroxygenase activity

#1928
20150258216
2015-09-17

MIR-21 PROMOTER DRIVEN TARGETED CANCER THERAPY

#1929
20150258213
2015-09-17

Nanotubes as carriers of nucleic acids into cells

#1930
20150258094
2015-09-17

Nanocarriers and their processing for diagnostics and therapeutics

#1931
20150252368
2015-09-10

Targets in multiple myeloma and other disorders

#1932
20150252365
2015-09-10

METHOD FOR SCREENING MICRORNAS WITH GENE SILENCING FUNCTION AT BOTH LEVELS OF TRANSCRIPTION AND POST-TRANSCRIPTION

#1933
20150240218
2015-08-27

Polypeptides having peroxygenase activity

#1934
20150238564
2015-08-27

Pharmaceutical composition comprising MicroRNA-30B, MicroRNA-133A, or MicroRNA-202-5P inhibitor for inhibiting cancer

#1935
20150232837
2015-08-20

MIRNA MODULATORS OF CHRONIC VISCERAL INFLAMMATION

#1936
20150231254
2015-08-20

POLYNUCLEOTIDE-POLY(DIOL) CONJUGATES, PROCESS OF PREPARATION AND USES THEREOF

#1937
20150225738
2015-08-13

Transgenic plant of the species solanum tuberosum with resistance to phytophthora

#1938
20150225721
2015-08-13

Methods and compositions using miR-3151 in the diagnosis and treatment of cancer

#1939
20150225719
2015-08-13

PHARMACEUTICAL COMPOSITION FOR TREATING LIVER DISEASES

#1940
20150225716
2015-08-13

MiRNA for treating head and neck cancer

#1941
20150218556
2015-08-06

Compositions and methods for treating peripheral arterial disease

#1942
20150218514
2015-08-06

PROMOTER OF DIFFERENTIATION FROM HEPATIC PROGENITOR CELL INTO HEPATIC CELL, AND USE THEREOF

#1943
20150216899
2015-08-06

Exosome-based therapeutics against neurodegenerative disorders

#1944
20150216892
2015-08-06

CELL-SPECIFIC DELIVERY OF MIRNA MODULATORS FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS

#1945
20150211071
2015-07-30

MIR-18B for use as a marker of cancer progression and target for therapies to treat cancer

#1946
20150211009
2015-07-30

MicroRNA-198 as a tumor suppressor in ovarian cancer

#1947
20150211008
2015-07-30

Post-synthetic chemical modification of RNA at the 2′-position of the ribose ring via “click” chemistry

#1948
20150211005
2015-07-30

MIRNA MODULATORS OF THERMOGENESIS

#1949
20150210760
2015-07-30

Therapeutic method for pancreatic cancer

#1950
20150209387
2015-07-30

Method for inducing immune tolerance using non-proliferative polymer-modified allogeneic leukocytes

#1951
20150209382
2015-07-30

MicroRNA-based approach to treating malignant pleural mesothelioma

#1952
20150209377
2015-07-30

Use of monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs

#1953
20150203847
2015-07-23

CHEMICAL MODIFICATIONS OF MONOMERS AND OLIGONUCLEOTIDES WITH CYCLOADDITION

#1954
20150203844
2015-07-23

Exosomes and micro-ribonucleic acids for tissue regeneration

#1955
20150203831
2015-07-23

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#1956
20150202298
2015-07-23

Compositions for targeted delivery of siRNA

#1957
20150197810
2015-07-16

DOWNREGULATION OF miR-218 MAY BE USED AS A BIOMARKER FOR HUMAN ALS

#1958
20150197761
2015-07-16

Method for controlling flowering time by regulating of SVP-FLM-β protein complex formation

#1959
20150197749
2015-07-16

Structurally designed shRNAs

#1960
20150197747
2015-07-16

Agent for treating cancer

#1961
20150196597
2015-07-16

Acellular pro-tolerogenic compositions for treatment/prevention of graft rejection

#1962
20150190391
2015-07-09

INHIBITORS OF NKX2.5 FOR VASCULAR REMODELLING

#1963
20150185202
2015-07-02

Simultaneous detection of cannibalism and senescence as prognostic marker for cancer

#1964
20150177248
2015-06-25

Use of SIRT7 as novel cancer therapy target and method for treating cancer using the same

#1965
20150176006
2015-06-25

Nucleic acids for down-regulation of gene expression

#1966
20150174260
2015-06-25

Amine-containing transfection reagents and methods for making and using same

#1967
20150174168
2015-06-25

Acellular pro-tolerogenic compositions and process for making same

#1968
20150167067
2015-06-18

Methods and compositions for universal detection of nucleic acids

#1969
20150167006
2015-06-18

Oligomeric compounds and methods

#1970
20150167003
2015-06-18

Gene vector

#1971
20150166993
2015-06-18

Plant microRNAs and methods of use thereof

#1972
20150166992
2015-06-18

Compositions and methods for inhibition of nucleic acids function

#1973
20150164948
2015-06-18

Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases

#1974
20150159159
2015-06-11

miR-520 microRNAs sensitize cancers to platinum-based therapy

#1975
20150159157
2015-06-11

MicroRNAs

#1976
20150157666
2015-06-11

Methods, systems, and compositions for cell-derived/vesicle-based microrna delivery

#1977
20150152421
2015-06-04

HEXIM-1 AS A TARGET OF LEPTIN SIGNALING TO REGULATE OBESITY AND DIABETES

#1978
20150152418
2015-06-04

Methods of treating vascular inflammatory disorders

#1979
20150152416
2015-06-04

NUCLEIC ACID MOLECULES AND COLLECTIONS THEREOF, THEIR APPLICATION AND MODIFICATION

#1980
20150152414
2015-06-04

Chemical modification of short small hairpin RNAs for inhibition of gene expression

#1981
20150152412
2015-06-04

siRNA compounds comprising terminal substitutions

#1982
20150150899
2015-06-04

Isoform of Bruton's Tyrosine Kinase (BTK) Protein

#1983
20150148405
2015-05-28

Expression Construct for a Lin28-Resistant Let-7 Precursor MicroRNA

#1984
20150141495
2015-05-21

DIFFERENTIAL EXPRESSION OF MICRORNAS IN NONFAILING VERSUS FAILING HUMAN HEARTS

#1985
20150141486
2015-05-21

Composition comprising miRNA for enhancing radiation sensitivity

#1986
20150140591
2015-05-21

CELL ENGINEERING USING RNAs

#1987
20150140067
2015-05-21

Therapeutic micro RNA targets in chronic pulmonary diseases

#1988
20150133522
2015-05-14

Manipulating microRNA for the management of neurological diseases or conditions and compositions related thereto

#1989
20150133330
2015-05-14

Methods and compositions useful for diagnosing inflammatory bowel disease-associated neoplasia

#1990
20150133319
2015-05-14

Compositions and kits for molecular counting

#1991
20150132226
2015-05-14

TREATMENT OF CANCER

#1992
20150125517
2015-05-07

miR-200 Family Induces Mesenchymal-to-Epithelial Transition (MET) in Ovarian Cancer Cells

#1993
20150125469
2015-05-07

Method of reducing the number of EMT and MET type breast cancer stem cells

#1994
20150125433
2015-05-07

Methods and compositions for the treatment of insulin-associated medical conditions

#1995
20150119450
2015-04-30

Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders

#1996
20150119449
2015-04-30

Methods and compositions for modulating MIR-204 activity

#1997
20150119443
2015-04-30

METHOD OF THERAPY AND DIAGNOSIS OF ENDOTHELIAL DYSFUNCTION

#1998
20150118230
2015-04-30

Pharmaceutical use of FAM19A5 involved in regulating gliogenesis

#1999
20150111954
2015-04-23

Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics

#2000
20150105449
2015-04-16

MicroRNA compounds and methods for modulating miR-122

#2001
20150105441
2015-04-16

LIM kinasemodulating agents for neurofibromatoses therapy and methods for screening for same

#2002
20150104870
2015-04-16

NEURONAL DIFFERENTIATION PROMOTER

#2003
20150104440
2015-04-16

MiRNA-31 AS A DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC AGENT IN CANCER

#2004
20150099793
2015-04-09

Rational design of microRNA-siRNA chimeras for multi-functional target suppression

#2005
20150096065
2015-04-02

Method of regulating gene expression

#2006
20150094357
2015-04-02

Methods for Differentiating Pancreatic Cancer from Normal Pancreatic Function and/or Chronic Pancreatitis

#2007
20150093433
2015-04-02

Targeted and modular exosome loading system

#2008
20150087693
2015-03-26

Micro-RNAs involved in macular degeneration

#2009
20150087607
2015-03-26

MICRORNA COMPOSITIONS AND METHODS

#2010
20150086613
2015-03-26

Lipid-derived neutral nanoparticles

#2011
20150086565
2015-03-26

Cancer-related extracellular matrix signatures and related methods and products

#2012
20150079161
2015-03-19

Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases

#2013
20150079046
2015-03-19

STEM CELL MICROPARTICLES

#2014
20150065561
2015-03-05

Compositions and methods for treating otitis media and other conditions with inhibitors of CYLD

#2015
20150065556
2015-03-05

THERAPEUTIC TARGETS FOR MITOCHONDRIAL DISORDERS

#2016
20150065554
2015-03-05

Neurofibromatoses therapeutic agents and screening for same

#2017
20150065431
2015-03-05

REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS

#2018
20150064237
2015-03-05

MEDICINAL COMPOSITION FOR TREATING INFARCTION

#2019
20150057336
2015-02-26

RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA

#2020
20150056630
2015-02-26

DNA controlling miR-140 expression, and screening method of drugs using said DNA

#2021
20150051264
2015-02-19

INHIBITORS OF NOX4 EXPRESSION AND /OR NOX4 FUNCTION AND THEIR USE IN THE PREVENTION AND TREATMENT OF NERVE INJURY AND/OR NEUROPATHIC PAIN

#2022
20150045414
2015-02-12

Trans-acting RNA switches

#2023
20150045412
2015-02-12

Use of the chromosome 19 microRNA cluster (C19MC) for treating viral disease and promoting authophagy

#2024
20150045411
2015-02-12

Pain treatment

#2025
20150045410
2015-02-12

METHOD OF REGULATING CFTR EXPRESSION AND PROCESSING

#2026
20150044239
2015-02-12

Compositions and Methods for Diagnosing, Preventing and Treating Intracranial Aneurysms

#2027
20150038552
2015-02-05

Esophageal microRNA expression profiles in eosinophilic esophagitis

#2028
20150037798
2015-02-05

Precursor miRNA loop-modulated target regulation

#2029
20150037403
2015-02-05

Use of miR-23a-3p and/or miR-27a-3p mimics as therapeutic agents for inhibition of neuronal apoptosis following brain injury

#2030
20150037299
2015-02-05

Generation of neural stem cells and motor neurons

#2031
20150037298
2015-02-05

MicroRNAs for the generation of astrocytes

#2032
20150037290
2015-02-05

Methods of modulating smooth muscle cell proliferation and differentiation

#2033
20150031751
2015-01-29

Compositions and methods for treatment of ovarian cancer

#2034
20150031749
2015-01-29

BIOMARKER, USES THEREOF AND THERAPY

#2035
20150031622
2015-01-29

RHOGEF12 IS A THERAPEUTIC TARGET FOR THE TREATMENT OF HEART FAILURE

#2036
20150031573
2015-01-29

MiRNA analysis methods

#2037
20150030610
2015-01-29

Increasing taxane sensitivity in cancer cells

#2038
20150024486
2015-01-22

Embryonic stem cell specific microRNAs promote induced pluripotency

#2039
20150024036
2015-01-22

Targeting RNAs to microvesicles

#2040
20150018539
2015-01-15

MODIFIED MIRNA AS A SCAFFOLD FOR SHRNA

#2041
20150018405
2015-01-15

Treatment of disease by modulation of SIRT6

#2042
20150011609
2015-01-08

MicroRNAs for cardiac regeneration through induction of cardiac myocyte proliferation

#2043
20150011478
2015-01-08

CMV GENE PRODUCTS PROMOTE CANCER STEM CELL GROWTH

#2044
20150011413
2015-01-08

Internal reference genes for microRNAs normalization and uses thereof

#2045
20150011401
2015-01-08

Cancer diagnostics using non-coding transcripts

#2046
20150010485
2015-01-08

Use of microrna molecules to influence skin pigmentation

#2047
20150005365
2015-01-01

Methods for diagnosing and treating learning or mental disorders

#2048
20150005362
2015-01-01

Methods and compositions for reducing viral genome amounts in a target cell

#2049
20150004695
2015-01-01

Lipid particle, nucleic acid transfer carrier, compound for manufacturing nucleic acid transfer carrier, method for manufacturing lipid particle, and gene transfer method

#2050
20150004656
2015-01-01

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#2051
20150004221
2015-01-01

Methods and compositions involving miRNA and miRNA inhibitor molecules

#2052
20150004186
2015-01-01

Modulation of T cell signaling threshold and T cell sensitivity to antigens

#2053
20140378528
2014-12-25

BIOMARKERS OF MIR-34 ACTIVITY

#2054
20140377324
2014-12-25

Pharmaceutical Composition Comprising miRNA-100 And Its Use In The Modulation of Blood Vessel Growth and Endothelial Inflammation

#2055
20140377277
2014-12-25

Treatment of vasculoproliferative conditions with Lrg1 antagonists

#2056
20140373199
2014-12-18

Polypeptides having beta-xylosidase activity and polynucleotides encoding same

#2057
20140357699
2014-12-04

Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart disease

#2058
20140357697
2014-12-04

Materials and methods related to modulation of mismatch repair and genomic stability by miR-155

#2059
20140357696
2014-12-04

RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis

#2060
20140351963
2014-11-27

MiRNAs Useful to Reduce Lung Cancer Tumorigenesis and Chemotherapy Resistance and Related Compositions and Methods

#2061
20140350090
2014-11-27

MicroRNA compounds and methods for modulating miR-122

#2062
20140350086
2014-11-27

Methods and compositions involving miRNA and miRNA inhibitor molecules

#2063
20140350085
2014-11-27

Sugar alcohol-based compositions for delivering nucleic acid-based drugs in vivo and in vitro

#2064
20140350069
2014-11-27

Methods and agents to increase therapeutic dystrophin expression in muscle

#2065
20140348907
2014-11-27

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

#2066
20140343131
2014-11-20

COMPOSITIONS AND METHODS FOR THE SUPPRESSION OF TARGET POLYNUCLEOTIDES FROM LYGUS

#2067
20140343130
2014-11-20

Micro-RNA Scaffolds, Non-naturally Occurring Micro-RNAs, and Methods for Optimizing Non-naturally Occurring Micro-RNAs

#2068
20140341930
2014-11-20

Systems and methods for diminishing cell growth and inducing selective killing of target cells

#2069
20140341908
2014-11-20

METHODS AND COMPOSITIONS TO MODULATE ANTIVIRAL AND IMMUNE ACTIVITY RESPONSES

#2070
20140336242
2014-11-13

Micro-RNA scaffolds and non-naturally occurring micro-RNAs

#2071
20140336241
2014-11-13

Compositions and methods for prognosis and treatment of prostate cancer

#2072
20140336240
2014-11-13

Method of treating hyperlipidemia and atherosclerosis with miR-30C

#2073
20140336239
2014-11-13

Compositions and methods for modulating myeloid derived suppressor cells

#2074
20140335605
2014-11-13

Anti-microRNA oligonucleotide molecules

#2075
20140335161
2014-11-13

Compositions and methods for the diagnosis and therapy of BCL2-associated cancers

#2076
20140335054
2014-11-13

CNS targeting AAV vectors and methods of use thereof

#2077
20140328858
2014-11-06

Lin28-mediated control of let-7 biogenesis

#2078
20140322169
2014-10-30

Recombinant virus products and methods for inhibition of expression of DUX4

#2079
20140314833
2014-10-23

Methods and compositions involving miRNA and miRNA inhibitor molecules

#2080
20140308674
2014-10-16

Characterizing melanoma

#2081
20140308340
2014-10-16

Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases

#2082
20140303362
2014-10-09

Reduction of off-target RNA interference toxicity

#2083
20140302057
2014-10-09

Inhibitors of metastasis

#2084
20140296319
2014-10-02

Composition for promoting apoptosis or inhibiting cell growth, comprising epstein-barr virus microrna

#2085
20140294943
2014-10-02

Methods of using microRNA 195 in providing neuroprotection

#2086
20140286896
2014-09-25

Methods of treating allergic inflammatory conditions by administering an anti-cadherin-like 26-based therapeutic

#2087
20140256792
2014-09-11

Compounds for the treatment of ischemic injury

#2088
20140256789
2014-09-11

Composition and methods for modulating cell proliferation and cell death

#2089
20140256591
2014-09-11

MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of ovarian cancer using a real-time PCR platform

#2090
20140249206
2014-09-04

Oligonucleotides for modulation of target RNA activity

#2091
20140243392
2014-08-28

MicroRNA-based methods and assays for osteosarcoma

#2092
20140242033
2014-08-28

Gene therapy vectors and cytosine deaminases

#2093
20140227778
2014-08-14

MicroRNA and methods for inhibiting same

#2094
20140227245
2014-08-14

Pharmaceutical angiogenic composition including a microRNA-382 activator

#2095
20140221463
2014-08-07

Methods for heart regeneration

#2096
20140221228
2014-08-07

Methods and compositions for amplification and detection of MicroRNAs

#2097
20140220574
2014-08-07

Methods for fixing and detecting RNA

#2098
20140220114
2014-08-07

Methods for treating Niemann-Pick type C disease

#2099
20140220049
2014-08-07

MicroRNA inhibition for the treatment of inflammation and myeloproliferative disorders

#2100
20140212395
2014-07-31

Downregulation of miR-7 for promotion of beta cell differentiation and insulin production